Identification of Novel Biomarkers and Pathways for Coronary Artery Calcification in Nondiabetic Patients on Hemodialysis Using Metabolomic Profiling | Zendy

Wei Chen | Zendy; Jessica Fitzpatrick | Zendy; Stephen M. Sozio | Zendy; Bernard G. Jaar | Zendy; Michelle M. Estrella | Zendy; Dario F. RiascosBernal | Zendy; Tong Tong Wu | Zendy; Yunping Qiu | Zendy; Irwin J. Kurland | Zendy; Ruth F. Dubin | Zendy; Yabing Chen | Zendy; Rulan S. Parekh | Zendy; David A. Bushinsky | Zendy; Nicholas E.S. Sibinga | Zendy

Open Access

Identification of Novel Biomarkers and Pathways for Coronary Artery Calcification in Nondiabetic Patients on Hemodialysis Using Metabolomic Profiling

Author(s) -

Wei Chen,

Jessica Fitzpatrick,

Stephen M. Sozio,

Bernard G. Jaar,

Michelle M. Estrella,

Dario F. RiascosBernal,

Tong Tong Wu,

Yunping Qiu,

Irwin J. Kurland,

Ruth F. Dubin,

Yabing Chen,

Rulan S. Parekh,

David A. Bushinsky,

Nicholas E.S. Sibinga

Publication year - 2020

Publication title -

kidney360

Language(s) - English

Resource type - Journals

ISSN - 2641-7650

DOI - 10.34067/kid.0004422020

Subject(s) - medicine , coronary artery disease , diabetes mellitus , odds ratio , chenodeoxycholic acid , deoxycholic acid , hemodialysis , gastroenterology , bile acid , endocrinology

A better understanding of the pathophysiology involving coronary artery calcification (CAC) in patients on hemodialysis (HD) will help to develop new therapies. We sought to identify the differences in metabolomics profiles between patients on HD with and without CAC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research